Trials / Conditions / Nonsquamous Non-small Cell Lung Cancer

Nonsquamous Non-small Cell Lung Cancer

9 registered clinical trials studyying Nonsquamous Non-small Cell Lung Cancer.

Status	Trial	Sponsor	Phase
Terminated	Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With NCT06173505	Xencor, Inc.	Phase 1 / Phase 2
Active Not Recruiting	HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally NCT05338970	Daiichi Sankyo	Phase 3
Active Not Recruiting	Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer NCT04736173	Arcus Biosciences, Inc.	Phase 2
Unknown	HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Ad NCT04750083	Taizhou Hanzhong biomedical co. LTD	Phase 2 / Phase 3
Completed	Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Ce NCT04262856	Arcus Biosciences, Inc.	Phase 2
Completed	Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenv NCT04716933	Merck Sharp & Dohme LLC	Phase 3
Unknown	A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With S NCT03863483	Xin-Hua Xu	Phase 2
Completed	Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenv NCT03829319	Merck Sharp & Dohme LLC	Phase 3
Unknown	A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage I NCT03830411	Xin-Hua Xu	Phase 2